Botulinum toxin injection: a review of injection principles and protocols

Botulinum toxin injection: a review of injection principles and protocols

Despite the favorable outcomes seen using botulinum toxin (BTX) for voiding dysfunction using BTX, a standardized technique and protocol for toxin injection is not defined. We reviewed the current literature on intravesical BTX injection for DO (detrusor overactivity). Specific attention was placed...

Full description

Bibliographic Details
Main Authors:	David E. Rapp, Alvaro Lucioni, Gregory T. Bales
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2007-04-01
Series:	International Brazilian Journal of Urology
Subjects:	botulinum toxin detrusor overactive techniques
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000200002

Similar Items

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Therapeutic Approaches of Botulinum Toxin in Gynecology
by: Marius Alexandru Moga, et al.
Published: (2018-04-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
by: Djamel Bensmail, et al.
Published: (2023-04-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
by: Fan-Ching Hung, et al.
Published: (2022-12-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
by: Hsiang-Ying Lee, et al.
Published: (2023-03-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
by: Yu-Hua Fan, et al.
Published: (2023-03-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK
by: R. Mohamed-Ahmed, et al.
Published: (2024-03-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
by: Naoki Wada, et al.
Published: (2022-09-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization
by: Jan Groen, et al.
Published: (2012-10-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Perioperative Techniques for the Use of Botulinum Toxin in Overactive Bladder: Results of a Multinational Online Survey of Urogynecologists in Germany, Austria, and Switzerland
by: Sören Lange, et al.
Published: (2023-02-01)

The use of botulinum toxin (BoNT) in urology - review
by: Jakub Szwed, et al.
Published: (2022-08-01)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
by: Cheng-Ling Lee, et al.
Published: (2022-01-01)

Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia
by: Yu-Hui Huang, et al.
Published: (2022-03-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

The role of Botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery
by: Shome Debraj, et al.
Published: (2007-01-01)

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use
by: Nastaran Namazi, et al.
Published: (2016-01-01)

Low dose intradetrusor injections of onabotulinumtoxina in women with overactive bladder symptoms or the painful bladder syndrome: unfavourable balance between clinical efficacy and the need for catheterisation
by: Jan Groen, et al.
Published: (2012-01-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Role of Botulinum toxin injection in neurological problems: A Short Review
by: Isha Dhungana, et al.
Published: (2016-10-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
by: Chung-Cheng Wang, et al.
Published: (2020-03-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Application of methylene blue as an improvement of the injection technique of botulinum toxin A in the treatment of refractory idiopathic overactive bladder: prospective, single-blind (patient-blind), randomized trial
by: Michał Szczypior, et al.
Published: (2019-02-01)

Ultrasound-guided botulinum toxin injections
by: S. E. Khatkova, et al.
Published: (2016-07-01)

Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01)

Persistent Facial Blanching after Botulinum Toxin Injection
by: Fouad Mitri, et al.
Published: (2022-08-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)